Frequent fragility of randomized controlled trials for HCC treatment

BACKGROUND: The fragility index (FI) of trial results can provide a measure of confidence in the positive effects reported in randomized controlled trials (RCTs). The aim of this study was to calculate the FI of RCTs supporting HCC treatments. METHODS: A methodological systematic review of RCTs in H...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hao, Li, Jingtao, Zeng, Wenting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034173/
https://www.ncbi.nlm.nih.gov/pubmed/33836710
http://dx.doi.org/10.1186/s12885-021-08133-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034173/
https://www.ncbi.nlm.nih.gov/pubmed/33836710
http://dx.doi.org/10.1186/s12885-021-08133-8

Ejemplares similares